Robot maker debuts on HK exchange


Accompanied by a humanoid robot developed by his company, Zhou Jian, chairman and CEO of UBTech Robotics, rings the opening bell at the Hong Kong Stock Exchange on Friday. CHINA DAILY

For the first time in its 132-year history, a humanoid robot rang the opening bell at the Hong Kong Stock Exchange on Friday, floating Shenzhen-based robot developer UBTech Robotics on the bourse for its final initial public offering of 2023.

Said by many to be “China”s first humanoid robot stock”, UBTech Robotics raised more than HK$1 billion ($130 million) on its first day of trading, as many domestic companies race to commercialize their humanoid robots.

According to a guideline unveiled by the Ministry of Industry and Information Technology, China aims to build an innovation system for humanoid robots by 2025, with breakthroughs to be made in key technologies to ensure the safe and effective supply of core components.

UBTech Robotics’ stock rose 0.94 percent to HK$90.85 on Friday, versus its IPO price of HK$90, giving the company a HK$38 billion market capitalization.

Zhou Jian, chairman and CEO of UBTech Robotics, said, “After going public, we will continue to improve the technological capabilities of humanoid robots, and use innovative technologies to solve major social problems.”

Zhou said the company focuses on three major application scenarios for humanoid robots, including industrial manufacturing, commercial services and as home companions.

Chen Jia, a researcher at the International Monetary Institute of the Renmin University of China, said, “Humanoid robots will be an industry field with great growth potential in the next decade, driven by the latest technological advancements in artificial intelligence.”

The global humanoid robot market is expected to grow at a rate of 52.8 percent per year from 2023 to 2030, according to market research company ReportLinker.

The China Institute of Electronics also forecast that the domestic scale of the market for humanoid robots is expected to reach about 870 billion yuan ($122 billion) by 2030.

However, currently, humanoid robots are still in their very early stages of development. There are shortcomings in the design of humanoid robots, and their functionalities are not in line with the demand of customers. Technological hurdles also exist, said Chen.

The affordability of such robots is another challenge for current market applications, experts added.

The average selling price of the UBTech Robotics Walker series of humanoid robots is about 6 million yuan, compared to its more basic educational robots, which are priced below 15,000 yuan on average.

Due to its heavy R&D investment, the company is still not profitable. Last year, UBTech Robotics recorded more than 1 billion yuan in revenue, with its R&D spend accounting for 42.5 percent. Last year, the company posted a 987-million-yuan net loss.

The Ministry of Industry and Information Technology released a guideline in November aimed at promoting the development of the humanoid robotics industry.

The guideline said it aims to cultivate two to three globally influential humanoid robotics enterprises, and a group of specialized small and medium-sized enterprises by 2025.

By 2027, China will see a secure and reliable industrial and supply chain system, and related products will be deeply integrated into the real economy, the guideline said.



Source link

Visited 1 times, 1 visit(s) today

Related Article

Plans to move Wise stock market listing to US approved by High Court judge

The plans were approved at the High Court (PA) (PA Archive) Plans for money transfer services provider Wise to move its primary stock market listing from the UK to the US have been approved by a High Court judge. The British company announced the proposal last June to switch its primary listing from the London

US Stock Market Today: S&P 500 Futures Edge Lower As Inflation Worries Linger

The Morning Bull – US Market Morning Update Monday, Apr, 27 2026 US stock futures are slightly softer this morning, with E mini S&P 500 contracts slipping about 0.1%, as investors weigh stubborn inflation worries against a resilient tech backdrop. The US 10 year Treasury yield sits near 4.32%, which keeps borrowing costs elevated for

Exploring 3 Undiscovered Gem Stocks In Europe

As European markets navigate a landscape marked by geopolitical tensions and economic uncertainties, the pan-European STOXX Europe 600 Index recently experienced a decline, reflecting broader market sentiment. In such an environment, identifying promising small-cap stocks requires careful consideration of factors like resilience to market volatility and potential for growth in traditionally defensive sectors. Name Debt

The Federal Reserve’s April Inflation Forecast Has Been Updated, and It’s a Good News-Bad News Scenario for Wall Street

Last week was another history-maker for Wall Street, with the benchmark S&P 500 (SNPINDEX: ^GSPC) and iconic Nasdaq Composite (NASDAQINDEX: ^IXIC) launching to record-closing highs. Although the Dow Jones Industrial Average (DJINDICES: ^DJI) didn’t reach a record high, it’s a stone’s throw away from one. Based on the performance of these indexes, you’d assume the

Novo Nordisk A/S – share repurchase programme

Bagsværd, Denmark, 27 April 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the “Safe Harbour Rules”). This programme is

The SpaceX IPO Timeline: Every Important Date and Time Frame You Need to Know

The S&P 500 (^GSPC +0.80%) and Nasdaq Composite (^IXIC +1.63%) aren’t the only things making history on Wall Street. Shortly, we’ll be witnessing the largest-ever initial public offering (IPO), courtesy of Elon Musk’s SpaceX. While several prominent private artificial intelligence superstars are expected to go public toward the end of this year, including OpenAI and

April 2026’s UK Stocks That May Be Trading Below Estimated Value

As the FTSE 100 and FTSE 250 indices experience downward pressure due to weak trade data from China and declining commodity prices, investors in the United Kingdom are closely monitoring market conditions for opportunities. In such an environment, identifying stocks that may be trading below their estimated value can offer potential benefits, as these investments

If a stock market crash is coming, this is the FTSE shares I want to buy

Image source: Getty Images Whether we’re talking about an impending stock market crash or something less dramatic, it’s clear some of us feel that share prices are looking a bit frothy. Last week, Sarah Breeden, deputy governor for the Bank of England (BoE), said the quiet part out loud: “There’s a lot of risk out

Pareto Securities cuts Cellavision price target to SEK 140 (200), reiterates Buy

Market Closed – Nasdaq Stockholm 12:00:00 2026-04-24 pm EDT 5-day change 1st Jan Change 120.20 SEK -21.54% -25.62% -23.54% Published on 04/27/2026 at 12:13 am EDT Finwire – Translated by Marketscreener Legal disclaimer Contact us to request a correction – See original Pareto Securities lowers its price target for Cellavision to SEK 140 (200) while

Undiscovered Gems in Middle East Stocks for April 2026

As Middle Eastern stock markets experience modest gains despite geopolitical tensions and economic challenges, investors are keenly observing the region’s small-cap companies for potential opportunities. In this environment, identifying stocks with strong fundamentals and resilience to external pressures can be crucial for navigating the complexities of the current market landscape. Name Debt To Equity Revenue

Sumitomo Pharma Co Ltd – Notice regarding withdrawal of shelf registration statement for issuance of new shares

Delayed Japan Exchange 10:30:00 2026-04-26 pm EDT 5-day change 1st Jan Change 1,950.50 JPY -5.36% -5.91% -15.85% Published on 04/26/2026 at 10:41 pm EDT Reuters © Reuters – 2026 DurationAuto.2 months3 months6 months9 months1 year2 years5 years10 yearsMax. PeriodDayWeek Sumitomo Pharma Co Ltd, formerly Sumitomo Dainippon Pharma Co Ltd, is a Japan-based pharmaceutical company. The

Broadcom Joins the $2 Trillion Club, and 4 of the 5 Vanguard ETFs That Just Underwent Stock Splits Hold It. Here’s an Even Better Low-Cost ETF for Long-Term Broadcom Investors.

Five low-cost exchange-traded funds (ETFs) operated by investment management firm Vanguard underwent stock splits on April 21. And Broadcom (AVGO +0.62%) is a top 10 holding in four of those five funds. The next day, on April 22, Broadcom hit an all-time high amid a broader stock market rally and Alphabet-related news. Broadcom is expanding

Graco (GGG) Valuation Check After Recent Share Price Moves

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE. Graco (GGG) has been drawing attention after recent share price moves, with the stock closing at US$81.58 as investors weigh its performance in contractor, industrial, and expansion market segments. See our latest analysis for Graco. Recent

Earnings Calendar for the Week: A Star-Studded Lineup on the Markets

Welcome to the corporate earnings calendar for the week of April 27 to May 1, 2026. The highlights this week include results from Microsoft, Exxon Mobil, LVMH, Alphabet, TotalEnergies, Airbus, Meta Platforms, BNP Paribas, Novartis and Samsung Electronics. Monday, April 27, 2026 US & Canada Verizon Communications, Inc.: Earnings Public Storage: Earnings Nucor Corporation: Earnings

ASX Growth Leaders With High Insider Ownership April 2026

As the Australian share market shows resilience with a +0.4% advance amidst global uncertainties, particularly contrasting Wall Street’s downturn, investors are keenly observing how local factors such as potential interest rate changes influence trading sentiment. In this environment, companies with high insider ownership often attract attention for their perceived alignment of interests between management and

Low Volatility Meets High Dividend Yield

Bristol Myers Squibb (NYSE: BMY) has been on a decent run over the past year, with the stock price climbing more than 20%. That may be surprising to some, as the company expects lower sales in 2026 than in 2025. On the surface, that does sound like enough to keep some investors away. Will AI

“Sounds Interesting, But Not 100% Up Interesting, Sell Some”

POET Technologies Inc. (NASDAQ:POET) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. Noting the stock’s parabolic move, Cramer said: Then there’s POET, Navitas, and Credo. These are all semiconductor networking stocks that have gone parabolic, each up around 100% this month. We profiled POET earlier

0
Would love your thoughts, please comment.x
()
x